Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2025-12-25 @ 2:00 AM
NCT ID:
NCT07051694
Eligibility Criteria:
Inclusion Criteria:
* Age 18-80
* Sepsis was diagnosed per the Sepsis-3 criteria (SCCM/ESICM 2016) as infection with SOFA score ≥ 2
* ICU admission within 7 days after sepsis onset
* Informed consent was obtained from patients/guardians
Exclusion Criteria:
* severe ARDS defined by PaO₂/FiO₂ ≤100 mmHg with PEEP ≥5 cm H₂O
* HR\>120 per minute
* epinephrine or norepinephrine \>1ug/kg/min
* severe underlying pulmonary diseases including interstitial lung disease, -
* diffuse alveolar hemorrhage, severe asthma, or lung cancer
* taVNS contraindications: existing pacemakers, cochlear implants, or other active implantable electronic medical devices
* dermatologic or infectious disorders affecting the auricular region
* pregnancy or lactation
* participation in other clinical trials
* inability to remain motionless during treatment (e.g., due to epilepsy or Parkinson's disease)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT07051694
Study Brief:
Protocol Section:
NCT07051694